Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Latest News, Synovial Sarcoma Registry

    Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    December 23, 2025 ayushis Comments Off on Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository
    A woman with short brown hair smiles at the camera outdoors. She is wearing a black sweater and a dark top, with light makeup and a natural background behind her.

    We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome our 100th registrant. This achievement signifies the growing commitment to advancing research and improving treatment options for patients with synovial sarcoma.

    The registry serves as a pivotal resource, collecting invaluable data and biospecimens from patients diagnosed with synovial sarcoma. By participating, patients contribute to a collective effort to understand this rare form of cancer better and develop innovative treatment plans that can lead to improved outcomes. Every registration helps researchers in their mission to tailor therapies more effectively, offering hope to individuals and families affected by this challenging condition.

    Meet Carrie Carpunky: Our 100th Registrant

    Among the many courageous individuals contributing to this critical endeavor is Carrie Carpunky, our milestone registrant. Carrie’s journey with cancer began in 2010, when she experienced persistent stomach pains attributed initially to stress and a possible ulcer. It wasn’t until she consulted a gastrointestinal specialist that the word “tumor” entered her reality, launching her into a whirlwind of tests, emotions, and eventually, a cancer diagnosis.

    A collage of five photos featuring a woman with brown hair, sometimes with a man or a younger woman, in various settings including outdoors, smiling selfies, and with a yellow “10 Years Free” shirt and red mask.

    Carrie’s story is one of resilience. After a partial gastrectomy procedure, she found herself grappling with the ramifications of her diagnosis. Yet through the ups and downs of her journey—including a tumor that remained localized against the odds and the anguish of watching her symptoms evolve—she found an incredible ally in her oncologist, Dr. Brian VanTine, who provided care and compassion throughout her experience.

    Following years of diligent monitoring and treatment, Carrie has reached a point where she goes for annual check-ups, underscoring the value of early intervention and unwavering support. The recent loss of Dr. VanTine deeply affected her. “He was more than my oncologist; he was a friend,” Carrie reflects, highlighting the bond that forms between patients and their healthcare providers.

    Get Involved

    We invite anyone diagnosed with synovial sarcoma to join the Synovial Sarcoma Registry and contribute to this crucial research effort. By participating, you are not only helping us build a comprehensive resource for researchers but also becoming part of a community that believes in the potential for better treatments and outcomes.

    To learn more about registering and participating in this vital initiative, please visit our official page: Synovial Sarcoma Registry.

    As we celebrate this milestone with Carrie and all our registrants, we renew our commitment to gathering insights that could drive breakthroughs in understanding synovial sarcoma. Together, we can make significant strides towards better therapies and, ultimately, a brighter future for those affected by this disease.

    Read Carrie’s journey here, and explore more stories from other patients by visiting our Patient Stories section. Each story offers a powerful reminder of the resilience within this community and the impact of collective participation in advancing research.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (4)
    • Dr. Theodore Laetsch (3)
    • Education (6)
    • Healthcare (4)
    • Latest News (6)
    • Research (14)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A virtual meeting with five professionally dressed people, each appearing in separate screens. Three men and two women are smiling or looking attentive, seated in well-lit indoor settings. Names and titles are visible on screen.
      Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum
    • Two scientists in protective clothing and masks work in a laboratory; one is looking through a microscope while the other stands beside, observing and discussing the research.
      Rethinking the Driver: New Research Identifies P300 as a Critical Co-Factor in Synovial Sarcoma
    • A doctor in a white coat and stethoscope writes on a clipboard while standing in a medical office or hospital room. Medical equipment and a bed are visible in the background.
      Synovial Sarcoma Treatment Market Projected to Grow Through 2031: What This Means for Patients

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant innovate treaments JAMA Internal Medicine Julie Kramer MAGE-A4 Market Growth Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications P300 Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TCR-NK TECELRA webinar Zelluna ZI-MA4-1

    Related posts

    A virtual meeting with five professionally dressed people, each appearing in separate screens. Three men and two women are smiling or looking attentive, seated in well-lit indoor settings. Names and titles are visible on screen.
    Latest News, Education

    Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    February 23, 2026 ayushis Comments Off on Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    On February 19, 2026, the Synovial Sarcoma Foundation brought together patients, families, clinicians, and researchers from around the world for its second community webinar—an evening focused on progress, partnership, and hope. The full webinar recording is available to watch below: The webinar was moderated by Nathan Imperiale, Chairman of the Board, and featured: Highlights Foundation […]

    A scientist wearing blue gloves holds a flask with blue liquid in a laboratory, surrounded by various glassware and a microscope in the background.
    Research, Latest News

    New Market Insights Highlight Growth in Synovial Sarcoma Treatments

    September 10, 2025 joshs Comments Off on New Market Insights Highlight Growth in Synovial Sarcoma Treatments

    The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive cancer. A recent market report indicates that the global synovial sarcoma market is projected to grow significantly, reaching an estimated USD 420 million by 2034 — up from USD 245 million in 2024, at a […]

    Close-up of the objective lenses of a microscope, showing three metal lenses labeled with magnification levels above a microscope stage—a vital tool in research supported by the Synovial Sarcoma Foundation.
    CHOP, Development, Dr. Theodore Laetsch, Research

    Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    June 3, 2025 joshs Comments Off on Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated pediatric oncology fellow from the Children’s Hospital of Philadelphia (CHOP), has been honored with the prestigious American Society of Clinical Oncology (ASCO) Young Investigator Award. Dr. Hurly conducts her research under the mentorship of Dr. Ted Laetsch at the Haldor Laboratory at the University of Pennsylvania, with support from the Synovial Sarcoma Fund.

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch